Molecular Data Inc. Announces Changes of Chief Financial Officer
Molecular Data Inc. (Nasdaq: MKD) has appointed Steven Foo as the new chief financial officer, effective December 1, 2020. He replaces Zhaohong Li, who resigned for personal reasons. The company appreciates Li's contributions, notably in its IPO and developing a finance team. Foo brings over 24 years of experience in investment, financing, and financial management, along with expertise in strategy and capital markets. Molecular Data operates in China's chemical industry, offering e-commerce, financial, and logistics solutions through its integrated platforms.
- Steven Foo's extensive 24-year background in finance may strengthen the company’s financial management.
- Foo's expertise in strategy and international markets aligns with the company's growth objectives.
- None.
SHANGHAI, China, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Molecular Data Inc. (“Molecular Data” or the “Company”) (Nasdaq: MKD), a leading technology-driven platform in China’s chemical industry, today announced that the Company has appointed Mr. Steven Foo as the new chief financial officer, effective December 1, 2020. Mr. Zhaohong Li has tendered his resignation as chief financial officer, for personal reasons.
“We greatly appreciate the contributions that Zhaohong has made during his tenure with the Company, leading our IPO, and building a public company finance team. We respect Zhaohong’s decision and wish him the very best in his future pursuits,” said Dr. Dongliang Chang, Founder and Chairman of the Board of Directors.
“Steven has an extensive finance background, and operating experience in key international markets. Coupled with his analyst and asset management background and his strategic transaction expertise, I believe Steven will help Molecular Data accelerate in its next phase of growth,” Dr. Chang added.
Mr. Foo brings over 24 years of investment, financing experience as well as financial management and restructuring work experience in Asia. Previously, Mr. Foo served as a member of the board of directors and chief financial officer of SOS Health Rescue Services. Prior to that, Mr. Foo served as a member of the board of directors and chief financial officer of Hebron Technology. Mr. Foo is a Fellow Chartered Accountant and Certified Public Accountant (CPA). In addition to his experience in securities laws and regulations compliance, Mr. Foo has extensive leadership experience in strategy, financial management and capital markets.
About Molecular Data Inc.
Molecular Data Inc. is a leading technology-driven platform in China’s chemical industry, connecting participants along the chemical value chain through integrated solutions. The Company delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and SaaS suite that are intended to solve pain points for participants in the traditional chemical industry. Built upon a comprehensive knowledge engine and artificial intelligence (AI) capabilities, the Company’s e-commerce solutions are mainly offered through its online platform, consisting of molbase.com, molbase.cn, Moku Data WeChat account, Chemical Community APP and other ancillary platforms.
For investor and media inquiries, please contact:
In China:
Molecular Data Inc.
Eva Ma
Tel: +86-21-6495-6998*8130
E-mail: investor@molbase.com
The Piacente Group, Inc.
Emilie Wu
Tel: +86-21-6039-8363
E-mail: molbase@tpg-ir.com
In the United States:
The Piacente Group, Inc.
Brandi Piacente
Tel: +1-212-481-2050
E-mail: molbase@tpg-ir.com
FAQ
Who is the new CFO of Molecular Data Inc. as of December 2020?
What led to the resignation of the previous CFO at Molecular Data?
What experience does Steven Foo bring to Molecular Data Inc.?
Is Molecular Data Inc. involved in e-commerce solutions?
What is the stock symbol for Molecular Data Inc.?
